ABSTRACT
The different sets of criteria for diagnosis or classification of anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) lead to numerous overlapping and reclassified diagnoses in clinical practice. We designed this study to assess the difficulties in classifying patients with AAV. As a secondary objective, different variables were tested to predict prognosis. We conducted a retrospective chart review in a Western Spain multicentre survey. A total of 115 adult patients diagnosed with AAV from 2002 to 2013 and followed for at least 3 years were included. They were classified according to (1) Chapel Hill Consensus Conference (CHCC), (2) European Medicines Agency algorithm and (3) French Vasculitis Study Group/European Vasculitis Society phenotypes. Fifty-three patients (46%) had neither distinctive histopathological data of a single AAV definition nor any surrogate markers for granulomatous inflammation and thus did not fulfill any diagnostic criteria. Ocular, ear, nose, throat, skin, and lung involvement were more frequent with proteinase 3 (PR3) antibodies, whereas peripheral neuropathy was more frequent with myeloperoxidase (MPO) antibodies. When the disease was severe at diagnosis, the HR for mortality was 10.44. When induction treatment was not given in accordance with the guidelines, the HR for mortality was 4.00. For maintenance treatment, the HR was 5.49 for mortality and 2.48 for relapse. AAV classification is difficult because many patients had neither specific clinical data nor distinctive histological features of a single CHCC definition. A structured clinical assessment of patient severity is the best tool to guide the management of AAV.
Subject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/classification , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/pathology , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/physiopathology , Mortality , Aged , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/immunology , Antibodies, Antineutrophil Cytoplasmic/immunology , Churg-Strauss Syndrome/classification , Churg-Strauss Syndrome/immunology , Churg-Strauss Syndrome/pathology , Churg-Strauss Syndrome/physiopathology , Epistaxis/immunology , Epistaxis/pathology , Epistaxis/physiopathology , Eye Diseases/immunology , Eye Diseases/pathology , Eye Diseases/physiopathology , Female , Gastrointestinal Diseases/immunology , Gastrointestinal Diseases/pathology , Gastrointestinal Diseases/physiopathology , Granulomatosis with Polyangiitis/classification , Granulomatosis with Polyangiitis/immunology , Granulomatosis with Polyangiitis/pathology , Granulomatosis with Polyangiitis/physiopathology , Humans , Hypertension/immunology , Hypertension/pathology , Hypertension/physiopathology , Kidney Diseases/immunology , Kidney Diseases/pathology , Kidney Diseases/physiopathology , Kidney Failure, Chronic/physiopathology , Lung Diseases/immunology , Lung Diseases/pathology , Lung Diseases/physiopathology , Male , Microscopic Polyangiitis/classification , Microscopic Polyangiitis/immunology , Microscopic Polyangiitis/pathology , Microscopic Polyangiitis/physiopathology , Middle Aged , Myeloblastin/immunology , Peripheral Nervous System Diseases/immunology , Peripheral Nervous System Diseases/pathology , Peripheral Nervous System Diseases/physiopathology , Peroxidase/immunology , Primary Prevention , Prognosis , Proportional Hazards Models , Recurrence , Retrospective Studies , Severity of Illness Index , Sinusitis/immunologyABSTRACT
INTRODUCTION: Besides the main treatment for their disease, hospital patients receive multiple care measures which include venous lines (VL), urinary catheters (UC), dietary restrictions (DR), mandatory bed rest (BR), deep venous thrombosis prophylaxis (VTP), stress ulcer prophylaxis (SUP) and anticoagulation bridge therapy for atrial fibrillation (BAF). In many cases these practices are of low value. METHODS: We analysed patients admitted to Internal Medicine wards throughout 2018 (2714 inpatients). We used different methodologies to identify low-value clinical practices. RESULTS: BR or DR at admission were recommended in 37% (32-44) and 24% (19-30) of the patients respectively. In 81% (71-87) and 33% (21-45) of the cases this restriction was deemed unnecessary. Ninety-six percent (92-98) had VL and 25% (19-32) UC. VL were not used in 10% (6-12), UC had no indications for insertion in 21% (11-35) and for maintenance in 31% (12-46) patients. Fifty-seven percent (49-64) of the patients were administered VTP and 69% (62-76) were prescribed SUP. Twenty-two percent (15-31) of patients with VTP and 52% (43-60) with SUP had no indication. Chronic anticoagulation for AF was interrupted in 65% (53-75) with BAF was prescribed in 38% (25-52) of them. An intervention to reduce low-value care supporting clinical practices addressed only to the Internal Medicine Wards showed very poor results. CONCLUSION: These results demonstrate that there is ample room for reduction of low-value care. Interventions to implement clinical guidelines at admissions should be addressed to cover the entire admission process, from the emergency room to the ward. Partial approaches are discouraged.
Subject(s)
Health Services Misuse/prevention & control , Patient Care/methods , Practice Guidelines as Topic , Unnecessary Procedures/statistics & numerical data , Adult , Evidence-Based Medicine , Hospitalization , Humans , Internal Medicine , Medicalization , Patients' Rooms , Quality Control , Tertiary Care CentersABSTRACT
We report a case of paradoxical deterioration. A male patient diagnosed with pleural tuberculosis, but who was not infected with human immunodeficiency virus (HIV), experienced clinical deterioration 3 weeks after the initiation of anti-tuberculous treatment. After other diagnoses were ruled out, a paradoxical response to treatment was established and the patient was started on systemic corticosteroids. Paradoxical response to treatment should be considered in patients with clinical deterioration after they start on anti-tuberculous treatment. LEARNING POINTS: The deterioration of patients with pleural tuberculosis during anti-tuberculous treatment should raise the suspicion of paradoxical response to treatment.Despite the clinical deterioration, patients should be kept on anti-tuberculosis treatment.There is no clear evidence concerning the benefits and harms of systemic corticosteroids or pleural drainage as additional treatment to control the patient's symptoms in this scenario.